➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
Baxter
Dow
Colorcon

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

Micro Labs Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MICRO LABS, and what generic and branded alternatives to MICRO LABS drugs are available?

MICRO LABS has forty-six approved drugs.

There are eight tentative approvals on MICRO LABS drugs.

Summary for Micro Labs
US Patents:0
Tradenames:43
Ingredients:43
NDAs:46
Patent Litigation for Micro Labs: See patent lawsuits for Micro Labs

Drugs and US Patents for Micro Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Micro Labs SIMVASTATIN simvastatin TABLET;ORAL 090383-002 Sep 16, 2011 AB RX No No   Start Trial   Start Trial
Micro Labs DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride INJECTABLE;INJECTION 205723-001 Aug 22, 2018 AP RX No No   Start Trial   Start Trial
Micro Labs DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 204777-001 May 28, 2020 AT RX No No   Start Trial   Start Trial
Micro Labs SIMVASTATIN simvastatin TABLET;ORAL 090383-004 Sep 16, 2011 AB RX No No   Start Trial   Start Trial
Micro Labs METHENAMINE HIPPURATE methenamine hippurate TABLET;ORAL 212172-001 Aug 1, 2019 AB RX No No   Start Trial   Start Trial
Micro Labs GLIMEPIRIDE glimepiride TABLET;ORAL 091220-001 Jun 29, 2012 AB RX No No   Start Trial   Start Trial
Micro Labs AMLODIPINE AND OLMESARTAN MEDOXOMIL amlodipine besylate; olmesartan medoxomil TABLET;ORAL 207435-003 Nov 2, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
McKinsey
AstraZeneca
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.